schedule at a glance

Register to the newsletter:

 

 

 

ACIES LOGOFrench National Research Agency Success Stories

Conferences for partnering opportunities

 

Since 2005, the French National Research Agency -ANR- has launched specific calls for proposals dedicated to biotech technology transfer and academic-industrial partnerships.Following a global strategy to mix efficiently academic and industrial partners' R&D culture, ANR has succeeded in creating the condition for an operational technology transfer process leading to real success stories.
ANR supports the whole technology transfer continuum from the early discoveries through the proof-of-concept validation and, further, clinical trials and industrial developments. From 2005 to 2007, ANR launched two dedicated programmes: the "Emergence" programme and the "Innovative Biotechnology Network" programme.

The "Emergence" programme was open to academic partners and consortiums in order to fund the proof-of-concept process, based on a rigorous evaluation of the projects' economic perspective, intellectual property background and scientific innovation. This programme allowed the emergence and the funding of ground-breaking technologies from their early stage up to their industrial uptake.

The "Innovative Biotechnology Network (RIB)" programme consisted in funding the technology transfer projects between academic and industrial partners. The selected projects had to be coordinated by industrial partners in order to secure the innovation developments with a clear market-oriented strategy.

 

Jointly, these programmes give SME and academic partners the opportunity to exchange technological solutions and best practices in a 'win-win' relation leading to a successful and accelerated development of their R&D programmes.


Considering existing biotech innovation support actions, what are the specificities of Emergence and Innovative Biotechnology Network -RIB- programmes led by the French National Research Agency (ANR)?

Emergence programme added value is to fill the funding gap surrounding the necessary maturation phase between promising scientific results and the proof-of-concept validation, making them ready for industrial development.
This programme is complemented by the RIB programme that goes a step further: it allows the financial support of technologies that have succeeded in the first steps of their maturation process and that need support to validate their proof-of-concept and, furthermore their next development steps such as clinical trials or first ready-to-market products development.

 

What do you think of EuroBIO 2009's ability to cluster partners on such programmes?

We do think that EuroBIO 2009 is a real opportunity to maximize the exchanges around such biotech innovation programmes. During this event, we will propose a whole-day "Key Partner Meeting" - based on proven success stories - and dedicated conferences, with more than 60 projects' leaders ready to create new valuable partnerships with actors interested in their products or expertises.

 

 

Aude SIRVEN, Ph.D


Emergence and RIB - Programme Officer
French National Research Agency (ANR)
Chairwoman session "Conferences for partnering opportunities

 

 

 

Thursday, September 24th

A WHOLE-DAY SESSION ON ANR KEY PARTNER MEETING AND DEDICATED CONFERENCES FOR PARTNERING OPPORTUNITIES

8h30 : Accueil des participants

 

9h00-9h15 : Introduction

M. Patrick CHAUSSEPIED | Directeur du Département Biologie Santé, ANR

 

9h15-9h40

Création de valeur pendant et à l'issue des projets partenariaux : les soutiens proposés par la Commission Européenne

 

M. Stéphane HOGAN | DG Research - Commission Européenne

 

9h40-12h30

Success-stories ANR en AGRO-ENVIRONNEMENT

 

Success-stories ANR en OUTILS BIOLOGIQUES DE RECHERCHE

 

12h30-14h00

Déjeuner-buffet partenarial et exposition des posters projets (Zone Exposants- Network Area )

 

14h15-14h40

Création de valeur au sein des PME innovantes et relais de croissance par l'intermédiaire des financements publics

 

M. Philippe POULETTY | DG de Truffle Capital

 

14h40-17h30

Success-stories ANR en THERAPEUTIQUE

Success-stories ANR en DIAGNOSTIC

 

17h30-17h45 : Conclusion

Mlle Aude SIRVEN | Responsable Programmes RIB/Emergence, Département Biologie Santé, ANR

 


© EuroBio 2009 | Credits | edikka
Co-organisers: |